BIOGEN (DENMARK) A/S — Credit Rating and Financial Key Figures

BIOGEN (DENMARK) A/S (CVR number: 21682977) is a company from KØBENHAVN. The company reported a net sales of 259.6 mDKK in 2023, demonstrating a decline of -15.6 % compared to the previous year. The operating profit percentage was at 3.5 % (EBIT: 9.2 mDKK), while net earnings were 8338.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 6 %, which can be considered decent and Return on Equity (ROE) was 6.2 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 69.9 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. BIOGEN (DENMARK) A/S's liquidity measured by quick ratio was 3.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.